BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 6, 2011
View Archived Issues
HIV-1 DNA/MVA-CMDR prime-boost vaccination evaluated in two clinical studies
Read More
Evaluation of kynurenine 3-monooxygenase as target for Huntington's disease therapy advances
Read More
NVA-237 shows efficacy in GLOW trials and is filed for marketing as COPD therapy in E.U.
Read More
Promising preclinical findings disclosed on new oxazolidinone antibiotics
Read More
Johnson & Johnson discloses first-in-human data on pan-histone deacetylase inhibitor
Read More
Bacterial DNA ligase inhibitors under development at AstraZeneca
Read More
NDA for mechlorethamine gel accepted for review by FDA
Read More
Novartis discloses new CFTR modulators
Read More
BioAlliance Pharma files for E.U. approval of Sitavir
Read More
Two phase III trials of LibiGel in female sexual dysfunction completed
Read More
Novel sirtuin modulators prepared by Sirtris Pharmaceuticals
Read More
New diagnostic agents for Alzheimer's disease patented by Bayer Schering Pharma
Read More
Celgene and Agios Pharmaceuticals expand cancer metabolism partnership
Read More
Transgene Biotek claims new antibodies targeting TNF receptor superfamily member 17
Read More
Dosing begins in phase II PEG-rHuPH20 study
Read More
BioCryst presents topline data from phase IIb BCX-4208 trial
Read More
Astellas Pharma discontinues development of coagulation factor X inhibitor
Read More
UX-001 receives FDA orphan drug status
Read More
New gold nanoparticles designed to treat bacterial infections
Read More
Evotec confirms second collaboration with UCB
Read More
Dynavax Technologies and AstraZeneca accelerate development of candidate asthma therapy
Read More
FDA accepts ridaforolimus NDA for filing
Read More
Study further elucidates activity of Adva-27a
Read More
Gilead obtains worldwide rights for novel HIV integrase inhibitors from Boehringer Ingelheim
Read More
FDA assigns PDUFA action date for Intermezzo NDA
Read More
Mymetics regains intranasal flu vaccine candidate from Solvay
Read More